Atherosclerosis and Hyperlipidemia

ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

Kausik Ray, , , et al

Watch time: 95m (4 videos)
AHA 22: RESPECT EPA: Eicosapentaenoic Acid for Prevention of Coronary Artery Disease

Hiroyuki Daida, Saahil A Jumkhawala,

Watch time: 14m 14s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 29s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 25s
EP 78: Your Guide to Lipoprotein(a) with Dr. Salim S Virani

Salim S Virani, Ankur Kalra,

Listen time: 46:28
ESC 22: 18F-NaF PET for Vulnerable Coronary Plaque imaging After MI

David Newby,

Watch time: 3:22

Hans-Willi Breuer ,

Alberto Lorenzatti , Peter P Toth ,

Ewa Dembowski , Michael H Davidson ,

Sumanth Khadke , Jovana Vidovic , Vinod Patel ,

Kausik Ray, , , et al

Watch time: 95m (4 videos)

Kerry Layne , Albert Ferro ,

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1:27:02

Cameron T Lambert , Pratik Sandesara , Ijeoma Isiadinso , et al

Iana Simova ,

Reynaria N Pitts , Robert H Eckel ,

Kazeen Abdullah , Anand Rohatgi ,

Yassir Javaid, , , et al

Watch time: 1h 6m (4 videos)

Media

ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

Kausik Ray, , , et al

Watch time: 95m (4 videos)
AHA 22: RESPECT EPA: Eicosapentaenoic Acid for Prevention of Coronary Artery Disease

Hiroyuki Daida, Saahil A Jumkhawala,

Watch time: 14m 14s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 29s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 25s
EP 78: Your Guide to Lipoprotein(a) with Dr. Salim S Virani

Salim S Virani, Ankur Kalra,

Listen time: 46:28
ESC 22: 18F-NaF PET for Vulnerable Coronary Plaque imaging After MI

David Newby,

Watch time: 3:22

Yassir Javaid, , , et al

Watch time: 1h 6m (4 videos)
4 Lipid Late-breaker Highlights from ACC.22 with Dr Erin Michos

Erin D Michos,

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1:27:02
Secondary Analysis of CANTOS Finds LDL & HDL Predict Residual Risk of Atherosclerotic Events

Paul M Ridker,

ACC 22: Magnitude & Duration of Effects of a siRNA Targeting Lp(a)

Steven E Nissen,

ACC 22: Results from the TRANSLATE-TIMI 70 Trial

ACC 2021 Discussion: The STRENGTH Study

Steven E Nissen, Harriette Van Spall,

ESC 2019 - Results of the Phase 3 ORION-11 trial

Kausik Ray,

ESC 2018: GLOBAL LEADERS TRIAL

Patrick W Serruys,

Randomized Placebo-Controlled Trial Of Anacetrapib interview with Christopher P. Cannon

Christopher P Cannon,

Articles

APSC Consensus Recommendations on Dyslipidaemia

Natalie Koh

,

Brian Ference

,

Stephen J Nicholls

,

Ann Marie Navar

,

Derek P Chew

,

Karam M Kostner

,

Ben He

,

Hung-Fat Tse

,

Jamshed J Dalal

,

Anwar Santoso

,

Junya Ako

,

Hayato Tada

,

Jin Joo Park

,

Mei Lin Ong

,

Eric Lim

,

Tavin Subramaniam

,

Yi-Heng Li

,

Arintaya Phrommintikul

,

SS Iyengar

,

Saumitra Ray

,

Kyung Woo Park

,

Hong Chang Tan

,

Narathip Chunhamaneewat

,

Khung Keong Yeo

,

Jack Wei Chieh Tan

,

Published:

09 December 2021

Citation:

European Cardiology Review 2021;16:e54.

DOI:

https://doi.org/10.15420/ecr.2021.36
  • Views: Views 1421
  • Downloads: Downloads 127
  • Citations: 2

The Role of C-reactive Protein in Patient Risk Stratification and Treatment

Ramón Arroyo-Espliguero

,

María Carmen Viana-Llamas

,

Alberto Silva-Obregón

,

Pablo Avanzas

,

Published:

07 July 2021

Citation:

European Cardiology Review 2021;16:e28.

DOI:

https://doi.org/10.15420/ecr.2020.49
  • Views: Views 2709
  • Downloads: Downloads 177

Inflammation and Cardiovascular Disease: The Future

Natalie Arnold

,

Katharina Lechner

,

Christoph Waldeyer

,

Michael D Shapiro

,

Wolfgang Koenig

,

Published:

17 May 2021

Citation:

European Cardiology Review 2021;16:e20.

DOI:

https://doi.org/10.15420/ecr.2020.50
  • Views: Views 2460
  • Downloads: Downloads 219
  • Citations: 23

The Association Between Psoriasis and Cardiovascular Diseases

Ahmed Zwain

,

Mohanad Aldiwani

,

Hussein Taqi

,

Published:

13 May 2021

Citation:

European Cardiology Review 2021;16:e19.

DOI:

https://doi.org/10.15420/ecr.2020.15.R2
  • Views: Views 1703
  • Downloads: Downloads 70
  • Citations: 5